U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:19:21 UTC 2021
Edited
by admin
on Sat Jun 26 18:19:21 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
A10SJL62JY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCRELIZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
RG-1594
Code English
OCRELIZUMAB [MI]
Common Name English
OCRELIZUMAB [USAN]
Common Name English
OCRELIZUMAB [PURPLE BOOK, CDER]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
Common Name English
OCRELIZUMAB [WHO-DD]
Common Name English
OCRELIZUMAB [JAN]
Common Name English
OCRELIZUMAB [INN]
Common Name English
PR-070769
Code English
PR070769
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
Common Name English
OCREVUS
Brand Name English
R-1594
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
NDF-RT N0000175657
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
NCI_THESAURUS C574
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
WHO-ATC L04AA36
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
Code System Code Type Description
CAS
637334-45-3
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
INN
8636
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
LACTMED
Ocrelizumab
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
ChEMBL
CHEMBL2108041
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
RXCUI
1876366
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
EVMPD
SUB121707
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
DRUG CENTRAL
5223
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
DRUG BANK
DB11988
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
NCI_THESAURUS
C66250
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
MERCK INDEX
M12020
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
FDA UNII
A10SJL62JY
Created by admin on Sat Jun 26 18:19:21 UTC 2021 , Edited by admin on Sat Jun 26 18:19:21 UTC 2021
PRIMARY
From To
1_22 1_96
1_149 1_205
1_225 3_213
1_231 2_231
1_234 2_234
1_266 1_326
1_372 1_430
2_22 2_96
2_149 2_205
2_225 4_213
2_266 2_326
2_372 2_430
3_23 3_87
3_133 3_193
4_23 4_87
4_133 4_193
Related Record Type Details
TARGET -> SUBSTRATE
TARGET->LIGAND
BINDING
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Molecular Formula CHEMICAL
Biological Half-life PHARMACOKINETIC
MOL_WEIGHT:SEQUENCE CHEMICAL